China NMPA Product Recall - Diffused braided artificial blood vessels

MAQUET Cardiovascular LLC initiated a voluntary Class II recall for its dipolluted braided artificial blood vessels, with Registration Certificate No.: 20173460601. This action, publicly announced by the National Medical Products Administration (NMPA) on August 27, 2019, stems from a potential issue concerning incorrect product packaging. The NMPA, serving as China's leading medical device regulatory body, oversees such recalls to safeguard public health.

The primary concern is that improper packaging could compromise the sterility or efficacy of these critical medical devices. Although the document does not specify inspection dates, the recall represents a proactive step by MAQUET Cardiovascular LLC to address and mitigate risks associated with the packaging discrepancy. A Class II recall signifies that the use of or exposure to the affected product might lead to temporary or medically reversible adverse health consequences, or where the likelihood of serious adverse health consequences is remote.

MAQUET Cardiovascular LLC is furnishing comprehensive details on affected product models, specifications, and batch numbers through a 'Medical Device Recall Event Report Form' to facilitate an organized recall process. The mandated action requires the removal of all affected units of the dipolluted braided artificial blood vessels from circulation, in adherence to the NMPA's stringent regulatory standards for medical device safety and quality assurance.